RT @reneroblesce: These findings indicated particular advantages of ALEMTUZUMAB compared to FINGOLIMOD in patients stopping NATALIZUMAB. W…
148 followers
1,080 followers
We heard similar data at ECTRIMS: #alemtuzumab is superior to #fingolimod after stopping natalizumab cessation." https://t.co/cTdZX63YiH #pubmed #feedly
1,967 followers
These findings indicated particular advantages of ALEMTUZUMAB compared to FINGOLIMOD in patients stopping NATALIZUMAB. Washout time was 63 days (mean) for FTY vs. 91 days (mean) for ALEM https://t.co/YjQ2huFZIY https://t.co/X95k098Mry
12,566 followers
Very useful paper to help sequencing of drugs. "Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation" https://t.co/j2vgy9UATb https://t.co/Mq5pc0p7pC